Delivery Order SPE2DR25D2005-SPE2DR26FE7T6
- Not listed
- The Defense Logistics Agency awarded a $22,379.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of December 2, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance...
- The Defense Logistics Agency awarded a $23,376.50 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 18, 2025, with an ultimate completion date of November 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,339.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of December 2, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $24,644.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. Performance will be executed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,724.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $33,395 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with a completion date of December 2, 2025. This non-set-aside contract represents a single delivery order fulfillment for typhoid vaccine product, leveraging AmerisourceBergen's established pharmaceutical distribution capabilities to support federal medical supply needs. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $4,936.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of September 2, 2025. This is an unset-aside, competitively awarded contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,931.44 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 mcg/0.5 mL syringes on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed price, non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a small-value transaction for a typhoid vaccine product, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical and medical...
- The Defense Logistics Agency awarded a $13,798 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract for a typhoid vaccine product. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,069.70 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement executed on September 5, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7T6Delivery Order
The Defense Logistics Agency awarded a $6,148.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of December 2, 2025. This non-set-aside contract represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply vehicle, which supports military healthcare programs and federal medical procurement needs globally. As a major pharmaceutical distributor and critical vendor for the Defense Health Agency and other government healthcare systems, AmerisourceBergen routinely fulfills federal requirements for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The typhoid vaccine supply under this order supports the company's role in providing essential medical commodities to military and defense-related healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 11/30/25 |